Corvus Pharmaceuticals, Inc (CRVS) Stock Price

8.51 ▼ -0.66 (-7.20%)
Open: 9.17 Vol: 888.27K Day's range: 8.31 - 9.17 Dec 01, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
CRVS Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY SELL SELL BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 8.51▲ 8.51▲ 8.57▼ 8.84▼ 8.52▼
MA10 8.48▲ 8.59▼ 8.77▼ 8.82▼ 7.92▲
MA20 8.48▲ 8.80▼ 8.90▼ 8.37▲ 6.71▲
MA50 8.60▼ 8.84▼ 8.79▼ 7.66▲ 5.23▲
MA100 8.79▼ 8.82▼ 8.65▼ 6.35▲ 4.52▲
MA200 8.93▼ 8.55▼ 8.11▲ 5.10▲ 2.96▲
  5 mins 30 mins Hourly Daily Weekly
MACD 0.017▲ -0.046▼ -0.071▼ -0.013▼ 0.204▲
RSI 48.760▼ 36.478▼ 36.282▼ 54.247▲ 65.902▲
STOCH 90.783▲ 15.473▼ 9.819▼ 61.696     82.974▲
WILL %R 0.000▲ -75.740▼ -76.571▼ -52.427     -21.658▲
CCI 100.419▲ -84.520     -111.355▼ -0.012     100.016▲
Latest Filters Detected On CRVS
▼ MACD $CRVS MACD(12,26,9) Crossed Below Signal Line Set Alert
MA $CRVS Price Crossed Below MA(13) Set Alert
MA $CRVS Price Crossed Below MA(7) Set Alert
Corvus Pharmaceuticals, Inc News
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2025 Financial Results
Saturday, November 22, 2025 10:17 AM
Completed enrollment in soquelitinib atopic dermatitis Phase 1 trial extension cohort 4 (200 mg BID dose with 8-week treatment period) with data announcement anticipated in January Soquelitinib atopic ...
Corvus Pharmaceuticals to Present Final Data from Soquelitinib Phase 1/1b T Cell Lymphoma Trial at the 67th American Society of Hematology Annual Meeting & Exposition
Monday, November 03, 2025 01:02 AM
SOUTH SAN FRANCISCO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that final data from its Phase 1 ...
Corvus Pharmaceuticals to Present Final Data from Soquelitinib Phase 1/1b T Cell Lymphoma Trial ...
Sunday, November 02, 2025 04:00 PM
SOUTH SAN FRANCISCO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that final data from its Phase 1 ...
CRVS historical stock data
date open high low close volume
01/12/25 9.17 9.17 8.31 8.51 888,267
28/11/25 9.10 9.18 8.935 9.17 460,754
26/11/25 8.83 9.32 8.75 9.07 995,458
25/11/25 8.56 8.92 8.49 8.87 725,958
24/11/25 8.60 8.77 8.50 8.58 959,691
21/11/25 8.51 8.80 8.34 8.57 764,471
20/11/25 9.10 9.19 8.47 8.51 679,176
19/11/25 9.09 9.22 8.86 8.90 742,780
18/11/25 8.7033 9.15 8.692 9.09 639,500
17/11/25 8.82 9.24 8.72 8.91 920,653
Quote Details
52wk Low:2.54
52wk High:9.32
Vol:888.27K
Avg Vol(3m):14.7M
1Y Chng:+23.33%
1M Chng:+13.92%
Add to Watch List
More Information
Index US Composite
Market Cap. 684.83M